EQS-News: Catalyst Crew Technologies Announces Receipt of Venezuelan Health Authority Approval for Telehealth Platform Operations

CARACAS, VENEZUELA - May 5, 2026 (NEWMEDIAWIRE) - Catalyst Crew Technologies Corp. (OTC: CCTC) (the “Company”), a digital health and artificial intelligence technology company developing telehealth infrastructure and healthcare analytics platforms for emerging markets, today announced that it has received a Permiso Sanitario de Funcionamiento para Plataforma Digital from the Venezuelan health authorities in connection with its telehealth platform operations.

The permit was issued by the Ministerio del Poder Popular para la Salud, through the Servicio Autonomo de Contraloría Sanitaria (SACS), and authorizes the operation of a digital healthcare platform under applicable Venezuelan regulatory frameworks. The permit has been granted following review by the applicable health authorities and authorizes operation subject to ongoing regulatory oversight and compliance.

The authorization has been granted in favor of LataMed AI VE, C.A. (“LATAMEDAIVE C.A.”), the Company’s Venezuelan operating entity associated with the Company’s regional healthcare infrastructure strategy, and represents a key regulatory milestone in the Company’s efforts to advance telehealth platform deployment and commercialization within Venezuela.

The permit has an initial validity period of two (2) years and is subject to ongoing regulatory oversight and compliance requirements as established by the applicable health authorities.

Management believes that receipt of this authorization represents a critical step in enabling the Company to advance from development and testing into broader operational execution and phased commercialization of its telehealth platform.

The Company is currently advancing operational readiness, infrastructure deployment, and commercialization planning, and expects to commence initial operational activities in the near term, subject to continued internal development and regulatory compliance alignment.

Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated: “Receiving this regulatory approval represents a major milestone for the Company and validates the foundation we have been building. We believe this authorization positions us to move forward with operational execution and begin advancing our telehealth platform within a regulated framework.” 

The Company’s telehealth platform, accessible through its development interface at https://latamedai.org, has been undergoing active testing, infrastructure refinement, and operational development in preparation for broader deployment.

The Company continues to coordinate with the Ministerio del Poder Popular para la Salud and SACS as part of its ongoing compliance, operational, and commercialization initiatives.

For more information, please visit https://catalystcrewai.com or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.

About Catalyst Crew Technologies Corp.

Catalyst Crew Technologies Corp. is an artificial intelligence-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The Company is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination.

Through technology development initiatives, strategic partnerships, and targeted acquisitions, CCTC is building an integrated healthcare technology platform positioned to address the growing demand for modernized healthcare delivery systems across emerging markets.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include, but are not limited to, statements regarding the Company’s business strategy, regulatory approvals, operational commencement, commercialization initiatives, strategic transactions, and future operations.

Forward-looking statements are based on current expectations and assumptions that involve risks and uncertainties. Actual results may differ materially from those expressed or implied due to various factors, including but not limited to the Company’s ability to successfully implement its business plan, secure financing, complete acquisitions, comply with regulatory requirements, and general market and economic conditions.

The Company undertakes no obligation to update any forward-looking statements except as required by applicable law.

Disclaimer

This press release is provided for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company.

The Company is a development-stage enterprise and has not generated revenues from its current business operations. There can be no assurance that the Company will successfully implement its business plan, complete acquisitions, secure financing, obtain regulatory approvals, or generate revenues.

Any investment decision should be made solely on the basis of information contained in the Company’s filings with the U.S. Securities and Exchange Commission and other publicly available documents. The Company’s securities involve a high degree of risk. Prospective investors are urged to carefully review all risk factors and disclosures contained in the Company’s SEC filings before making any investment decision.

No representation or warranty, express or implied, is made as to the accuracy or completeness of the information contained herein.

Investor Relations Contact +1 (787) 476-2350 ir@catalystcrew.ai